Burow Kristina's Form 4 filing
Neumora Therapeutics, Inc. (NMRA) · filed Sep 25, 2023
- Accession no.
- 0001062993-23-018468
- Filed
- Sep 25, 2023
- Trade date
- Sep 22-25, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $1.13M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burow KristinaCIK 0001569248 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2023 | Common Stock | PPurchaseAcquired | +40,000 | $11.14 | +$445,600 | 3,664,143 | Indirect | |
| Sep 25, 2023 | Common Stock | PPurchaseAcquired | +30,773 | $10.80 | +$332,348.4 | 3,694,916 | Indirect | |
| Sep 25, 2023 | Common Stock | PPurchaseAcquired | +29,967 | $11.65 | +$349,115.55 | 3,724,883 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.